Literature DB >> 34035302

Activation of Prp28 ATPase by phosphorylated Npl3 at a critical step of spliceosome remodeling.

Fu-Lung Yeh1, Shang-Lin Chang1, Golam Rizvee Ahmed1, Hsin-I Liu1, Luh Tung1, Chung-Shu Yeh1, Leah Stands Lanier2, Corina Maeder3, Che-Min Lin1, Shu-Chun Tsai1, Wan-Yi Hsiao1,4, Wei-Hau Chang5, Tien-Hsien Chang6.   

Abstract

Splicing, a key step in the eukaryotic gene-expression pathway, converts precursor messenger RNA (pre-mRNA) into mRNA by excising introns and ligating exons. This task is accomplished by the spliceosome, a macromolecular machine that must undergo sequential conformational changes to establish its active site. Each of these major changes requires a dedicated DExD/H-box ATPase, but how these enzymes are activated remain obscure. Here we show that Prp28, a yeast DEAD-box ATPase, transiently interacts with the conserved 5' splice-site (5'SS) GU dinucleotide and makes splicing-dependent contacts with the U1 snRNP protein U1C, and U4/U6.U5 tri-snRNP proteins, Prp8, Brr2, and Snu114. We further show that Prp28's ATPase activity is potentiated by the phosphorylated Npl3, but not the unphosphorylated Npl3, thus suggesting a strategy for regulating DExD/H-box ATPases. We propose that Npl3 is a functional counterpart of the metazoan-specific Prp28 N-terminal region, which can be phosphorylated and serves as an anchor to human spliceosome.

Entities:  

Year:  2021        PMID: 34035302     DOI: 10.1038/s41467-021-23459-4

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  38 in total

1.  Specific alterations of U1-C protein or U1 small nuclear RNA can eliminate the requirement of Prp28p, an essential DEAD box splicing factor.

Authors:  J Y Chen; L Stands; J P Staley; R R Jackups; L J Latus; T H Chang
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

2.  An RNA switch at the 5' splice site requires ATP and the DEAD box protein Prp28p.

Authors:  J P Staley; C Guthrie
Journal:  Mol Cell       Date:  1999-01       Impact factor: 17.970

3.  A targeted bypass screen identifies Ynl187p, Prp42p, Snu71p, and Cbp80p for stable U1 snRNP/Pre-mRNA interaction.

Authors:  Rosemary Hage; Luh Tung; Hansen Du; Leah Stands; Michael Rosbash; Tien-Hsien Chang
Journal:  Mol Cell Biol       Date:  2009-05-18       Impact factor: 4.272

Review 4.  Molecular Mechanisms of pre-mRNA Splicing through Structural Biology of the Spliceosome.

Authors:  Chuangye Yan; Ruixue Wan; Yigong Shi
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-01-02       Impact factor: 10.005

Review 5.  Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes.

Authors:  Berthold Kastner; Cindy L Will; Holger Stark; Reinhard Lührmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-11-01       Impact factor: 10.005

Review 6.  Structural Basis of Nuclear pre-mRNA Splicing: Lessons from Yeast.

Authors:  Clemens Plaschka; Andrew J Newman; Kiyoshi Nagai
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-05-01       Impact factor: 10.005

7.  The human U5 snRNP-specific 100-kD protein is an RS domain-containing, putative RNA helicase with significant homology to the yeast splicing factor Prp28p.

Authors:  S Teigelkamp; C Mundt; T Achsel; C L Will; R Lührmann
Journal:  RNA       Date:  1997-11       Impact factor: 4.942

8.  Yeast precursor mRNA processing protein PRP19 associates with the spliceosome concomitant with or just after dissociation of U4 small nuclear RNA.

Authors:  W Y Tarn; K R Lee; S C Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

9.  PRP28, a 'DEAD-box' protein, is required for the first step of mRNA splicing in vitro.

Authors:  E J Strauss; C Guthrie
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

10.  Crystal structure, mutational analysis and RNA-dependent ATPase activity of the yeast DEAD-box pre-mRNA splicing factor Prp28.

Authors:  Agata Jacewicz; Beate Schwer; Paul Smith; Stewart Shuman
Journal:  Nucleic Acids Res       Date:  2014-10-10       Impact factor: 16.971

View more
  1 in total

1.  Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1.

Authors:  Chen Zhao; Yingwei Li; Chunping Qiu; Jingying Chen; Huan Wu; Qiuman Wang; Xinyue Ma; Kun Song; Beihua Kong
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.